Healthcare
Bonesupport Holding AB(BOEUF)
Live Price
Offline$22.79
+0.00% today
Window Change
-14.37%
Window
May 29, 2026 β Jun 22, 2026
- Market Cap
- $14.70B
- Revenue Growth
- +30.4%
- EPS Growth
- +3.9%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 17 bars Β· May 29, 2026 β Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Bonesupport Holding AB (BOEUF) is a Healthcare stock with a market cap of $14.70B and listed on OTC. The stock last traded around $22.79 and down 14.4% across the available one-year price window (May 29, 2026 β Jun 22, 2026). Baseline metrics include revenue growth of +30.4%, EPS growth of +3.9%, a dividend yield of 0.0%. What stands out right now is revenue +30.4%, EPS +3.9%, free cash flow +264.5% with operating margin 22.8% and ROIC 21.0%. Valuation already assumes a fairly strong business story at P/E 79.4 and price/sales 12.1. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines BOEUF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+30.4% vs +7.6% peer median
Operating Margin
Above sector median
+22.8% vs +19.4% peer median
P/E
Above sector median
79.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 22, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +30.4% and EPS at +3.9%, with operating margin around 22.8%.
Benchmark Edge
BOEUF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BOEUF
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BOEUF Max Drawdown
-14.37%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for BOEUF and SPY.
Company Overview
Bonesupport Holding AB
OTC
BONESUPPORT HOLDING AB is a Swedish orthobiologics company headquartered in Lund, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes. Its flagship technology platform, CERAMENT, produces synthetic, osteoconductive biomaterials that remodel into the patientβs own bone within 6 to 12 months and can elute antibiotics like gentamicin for infection control. These products treat conditions such as fragility fractures from osteoporosis, bone voids from trauma or surgery, benign tumors, and osteomyelitis, supporting orthopedic procedures including fracture augmentation and spine support. Founded in 1999 by Professor Lars Lidgren, the company has raised over SEK 500 million in venture capital and went public on Nasdaq Stockholm in 2017. CERAMENT received FDA approval in 2005 and CE marking in 2009, with CERAMENT G designated a breakthrough device by the FDA in 2020. In 2024, BONESUPPORT HOLDING AB reported net sales of SEK 899 million, underscoring its growing role in the global medical device market for bone healing solutions.
- Leadership
- Mr. Ahmed Khaled El-Hoshy
- Employees
- 160
- Street Address
- ScheelevΓ€gen 19, 11 Bermudiana Road
- Mailing
- Lund, MI, 223 70
- Region
- Lund, MI, Sweden
- Last Updated
- May 7, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 79.4
- EV/EBITDA
- 51.4
- Price/Sales
- 12.1
- Price/Book
- 15.7
Growth
- Revenue
- +30.4%
- EPS
- +3.9%
- Free Cash Flow
- +264.5%
Profitability
- Gross Margin
- 92.5%
- Operating Margin
- 22.8%
- Net Margin
- 15.2%
- ROE
- 21.5%
- ROIC
- 21.0%
Balance Sheet
- Debt/Equity
- 0.02
- Current Ratio
- 5.13
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.